With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
Mark McClellan, MD, PhD, Director and Robert J. Margolis, MD, Professor of Business, Medicine and Policy, Duke University
Remarks and Presentations
Tony Culyer, Emeritus Professor of Economics and iDSI Chair, Centre for Health Economics, University of York
Amanda Glassman, Chief Operating Officer and Senior Fellow, Center for Global Development
Karen Hofman, Director, PRICELESS SA (Priority Cost Effective Lessons for Systems Strengthening), Wits School of Public Health, South Africa
Waranya Rattanavipapong, Head of HITAP International Unit, Health Intervention and Technology Assessment Program, HITAP Thailand
Kalipso Chalkidou, Director of Global Health Policy, Center for Global Development
Five years after the landmark UN endorsement, countries around the world are now working to translate the lofty rhetoric of UHC into defined, tangible, equitable, and comprehensive health services for their populations. On December 12th, the world will officially mark the 5th annual Universal Health Coverage (UHC) Day—an opportunity to reflect on the global community’s role in supporting progress toward this important goals.
In celebration of UHC day, the Center for Global Development is pleased to host a short program—Better Decisions, Better Health: Practical Experiences Supporting UHC from around the World—featuring practical experiences supporting UHC from Southeast Asia, Sub-Saharan Africa, and at the global level. A keynote address from Mark McClellan will precede remarks and presentations from the core partners of the International Decision Support Initiative (iDSI).
Successful suppression of COVID-19 in the United States will require urgent and decisive action by state, local, and community leaders across the country. To support effective decision-making, top global health security leaders have released a COVID-19 Frontline Guide. Developed in response to calls from local governments for more information on how to protect their communities, the online tool features eight indicators of progress for self-assessment and seven key actions that each include checklists of decision points. The guide provides a framework to help local leaders establish effective strategies to fight the outbreak, both by reducing transmission of the disease and by supporting their communities effectively. The website and guide will be discussed at an online webinar on Tuesday, March 31 at 12:30 pm ET. Register below, and we will provide the Zoom information before the event.
Aid agencies are scrambling to adapt as the COVID-19 pandemic is felt throughout the world. Join TNH Senior Editor Ben Parker as he speaks to leading experts and practitioners from across the humanitarian sector to discuss some of the most pressing issues. How will COVID-19 impact crisis-affected and already-vulnerable communities? How is the humanitarian sector adjusting to life under the shadow of a new global pandemic? Where should priorities lie? And what does this crisis reflect about the changing face of vulnerability?
Novartis Access is a new line of mostly branded generic NCD medicines offered at a wholesale price of US$1 per treatment per month. Please join us for a seminar featuring Peter Rockers and Veronika Wirtz, who will present findings from recent and ongoing work examining Novartis Access in Kenya, the first country to receive the program. The researchers will first present evidence from a randomized controlled trial of the impact of Novartis Access on the price and availability of NCD medicines at health facilities and households. They will then present evidence from their latest analysis, which explores patient willingness-to-pay (WTP) for Novartis Access-branded generics compared to unbranded generic equivalents. The researchers will discuss their findings in light of current policy reforms in Kenya. Finally, the seminar will examine lessons learned from the RCT of Novartis Access and its potential implications for other pharmaceutical companies, along with the broader global health community, in developing and implementing programs to improve access to medicines.
In Capitalism, Alone, Branko Milanovic argues that capitalism has triumphed because it works. It delivers prosperity and gratifies human desires for autonomy. But it comes with a moral price, pushing us to treat material success as the ultimate goal. And it offers no guarantee of stability. In the West, liberal capitalism creaks under the strains of inequality and capitalist excess. That model now fights for hearts and minds with political capitalism, exemplified by China, which many claim is more efficient, but which is more vulnerable to corruption and, when growth is slow, social unrest. As for the economic problems of the Global South, Milanovic offers a creative, if controversial, plan for large-scale migration. Looking to the future, he dismisses prophets who proclaim some single outcome to be inevitable, whether worldwide prosperity or robot-driven mass unemployment. Capitalism is a risky system. But it is a human system. Our choices, and how clearly we see them, will determine how it serves us.